Furthermore, Yi et al. have shown that binding of OPN to αvβ3 activates the PI3K/Akt/GSK3β/β-catenin signaling cascade, resulting in cell survival and sorafenib insensitivity in FLT3-ITD mutant AML cells [88]. This evidence concerns the gene SPP1 and acute myeloid leukemia.